InMed Pharmaceuticals Inc. (TSE:IN – Get Free Report)’s share price dropped 1.6% during trading on Monday . The stock traded as low as C$4.13 and last traded at C$4.19. Approximately 17,035 shares were traded during mid-day trading, a decline of 42% from the average daily volume of 29,552 shares. The stock had previously closed at C$4.26.
InMed Pharmaceuticals Stock Down 1.6 %
The company has a debt-to-equity ratio of 8.48, a quick ratio of 1.45 and a current ratio of 2.13. The company has a 50 day moving average price of C$4.19. The firm has a market capitalization of C$33.73 million and a PE ratio of -2.77.
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain.
Featured Stories
- Five stocks we like better than InMed Pharmaceuticals
- Using the MarketBeat Stock Split Calculator
- Intel: Is Now the Time to Be Brave?Â
- The Role Economic Reports Play in a Successful Investment Strategy
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Learn Technical Analysis Skills to Master the Stock Market
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
